Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0746.HK Stock Summary
Top 10 Correlated ETFs
0746.HK
In the News
0746.HK Financial details
Company Rating
Buy
Market Cap
2.81B
Income
1.56B
Revenue
9.92B
Book val./share
-
Cash/share
-
Dividend
0.22
Dividend %
7.61%
Employees
2.1K
Optionable
No
Shortable
Yes
Earnings
08 Mar 2024
P/E
6.64
Forward P/E
2.91
PEG
1.9
P/S
0.52
P/B
0.44
P/C
-
P/FCF
6.55
Quick Ratio
0.15
Current Ratio
1.33
Debt / Equity
0.12
LT Debt / Equity
-
-
-
EPS (TTM)
1.89
EPS next Y
1.11
EPS next Q
-
EPS this Y
-65%
EPS next Y
-41.32%
EPS next 5Y
-32.06%
EPS last 5Y
-10.43%
Revenue last 5Y
3.1%
Revenue Q/Q
2.92%
EPS Q/Q
176.92%
-
-
-
-
SMA20
13.27%
SMA50
14.83%
SMA100
8.47%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
6%
ROC
0.08%
Gross Margin
24%
Oper. Margin
10%
Profit Margin
8%
Payout
123%
Shs Outstand
825M
Shs Float
206.25M
-
-
-
-
Target Price
-
52W Range
2.67-5.42
52W High
-35.4%
52W Low
+61.5%
RSI
53.06
Rel Volume
1.67
Avg Volume
88.49K
Volume
148K
Perf Week
-4.72%
Perf Month
17.88%
Perf Quarter
-2.42%
Perf Half Y
2.54%
-
-
-
-
Beta
0.503
-
-
Volatility
0.08%, 0.21%
Prev Close
-0.31%
Price
3.23
Change
-1.52%
0746.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.21 | 3.76 | 6.29 | 7.11 | 4.91 | |
Net income per share | 0.85 | 0.61 | 1.56 | 1.4 | 0.49 | |
Operating cash flow per share | 1.14 | 1 | 1.74 | 1.9 | 0 | |
Free cash flow per share | 0.35 | 0.42 | 0.92 | 1.16 | 0 | |
Cash per share | 0.3 | 0.51 | 0.39 | 0.51 | 0.32 | |
Book value per share | 4.67 | 5.39 | 6.76 | 6.83 | 7.03 | |
Tangible book value per share | 4.55 | 5.26 | 6.63 | 6.72 | 7.03 | |
Share holders equity per share | 4.67 | 5.39 | 6.76 | 6.83 | 7.03 | |
Interest debt per share | 1.91 | 1.93 | 1.31 | 0.95 | 0.86 | |
Market cap | 2.86B | 2.87B | 6.51B | 5.36B | 2.45B | |
Enterprise value | 4.12B | 3.99B | 7.22B | 5.69B | 2.87B | |
P/E ratio | 4.09 | 5.71 | 5.05 | 4.64 | 6.12 | |
Price to sales ratio | 0.82 | 0.93 | 1.26 | 0.91 | 0.6 | |
POCF ratio | 3.05 | 3.47 | 4.54 | 3.42 | 0 | |
PFCF ratio | 9.87 | 8.24 | 8.54 | 5.61 | 0 | |
P/B Ratio | 0.74 | 0.65 | 1.17 | 0.95 | 0.42 | |
PTB ratio | 0.74 | 0.65 | 1.17 | 0.95 | 0.42 | |
EV to sales | 1.18 | 1.29 | 1.39 | 0.97 | 0.71 | |
Enterprise value over EBITDA | 4.75 | 6.6 | 4.42 | 3.88 | 3.29 | |
EV to operating cash flow | 4.39 | 4.82 | 5.03 | 3.63 | 0 | |
EV to free cash flow | 14.19 | 11.44 | 9.48 | 5.95 | 0 | |
Earnings yield | 0.24 | 0.18 | 0.2 | 0.22 | 0.16 | |
Free cash flow yield | 0.1 | 0.12 | 0.12 | 0.18 | 0 | |
Debt to equity | 0.39 | 0.35 | 0.19 | 0.13 | 0.12 | |
Debt to assets | 0.25 | 0.23 | 0.14 | 0.11 | 0.1 | |
Net debt to EBITDA | 1.45 | 1.85 | 0.44 | 0.22 | 0.48 | |
Current ratio | 1.24 | 1.52 | 1.6 | 1.51 | 1.29 | |
Interest coverage | 10.54 | 9.47 | 31.78 | 35.91 | 12.05 | |
Income quality | 1.34 | 1.65 | 1.11 | 1.35 | 0 | |
Dividend Yield | 0.1 | 0.06 | 0.05 | 0.11 | 0 | |
Payout ratio | 0.39 | 0.37 | 0.27 | 0.5 | 0 | |
Sales general and administrative to revenue | 0.06 | 0.07 | 0.06 | 0.05 | 0 | |
Research and developement to revenue | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | |
Intangibles to total assets | 0.02 | 0.02 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.69 | -0.58 | -0.47 | -0.39 | 0 | |
Capex to revenue | -0.19 | -0.15 | -0.13 | -0.1 | 0 | |
Capex to depreciation | -13.84 | -9.35 | -11.8 | -7.95 | 0 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Graham number | 9.44 | 8.59 | 15.41 | 14.68 | 8.76 | |
ROIC | 0.13 | 0.07 | 0.19 | 0.18 | 0.06 | |
Return on tangible assets | 0.12 | 0.08 | 0.17 | 0.17 | 0.06 | |
Graham Net | -1.59 | -1.45 | -0.97 | -0.44 | -0.38 | |
Working capital | 293.85M | 606.21M | 807.25M | 574.83M | 341.16M | |
Tangible asset value | 3.75B | 4.34B | 5.47B | 5.54B | 5.8B | |
Net current asset value | -706.39M | -554.86M | 102.91M | 265.33M | 283.76M | |
Invested capital | 0.39 | 0.35 | 0.19 | 0.13 | 0.12 | |
Average receivables | 292.76M | 358.08M | 414.9M | 381.62M | 320.78M | |
Average payables | 222.2M | 231.38M | 205.8M | 185.79M | 171.32M | |
Average inventory | 709.22M | 863.89M | 1.02B | 1.01B | 837.03M | |
Days sales outstanding | 37.49 | 42.28 | 33.13 | 18.2 | 31.45 | |
Days payables outstanding | 41.72 | 41.51 | 24.07 | 17.92 | 19.4 | |
Days of inventory on hand | 145.36 | 166.03 | 145.7 | 86.42 | 96.21 | |
Receivables turnover | 9.74 | 8.63 | 11.02 | 20.06 | 11.6 | |
Payables turnover | 8.75 | 8.79 | 15.16 | 20.37 | 18.81 | |
Inventory turnover | 2.51 | 2.2 | 2.51 | 4.22 | 3.79 | |
ROE | 0.18 | 0.11 | 0.23 | 0.21 | 0.07 | |
Capex per share | -0.78 | -0.58 | -0.82 | -0.74 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.32 | 3.94 | 3.17 | 2.42 | 0 | |
Net income per share | 0.8 | 1.08 | 0.32 | 0.13 | 0 | |
Operating cash flow per share | 0.88 | 1.06 | 0.84 | 0.31 | 0 | |
Free cash flow per share | 0.53 | 0.79 | 0.37 | -0.05 | 0 | |
Cash per share | 0.37 | 0.43 | 0.51 | 0.2 | 0 | |
Book value per share | 6.35 | 7.25 | 6.83 | 6.78 | 0 | |
Tangible book value per share | 6.23 | 7.13 | 6.72 | 6.67 | 0 | |
Share holders equity per share | 6.35 | 7.25 | 6.83 | 6.78 | 0 | |
Interest debt per share | 1.21 | 0.78 | 0.93 | 0.89 | 0 | |
Market cap | 6.93B | 5.42B | 5.36B | 3.9B | 0 | |
Enterprise value | 7.64B | 5.69B | 5.69B | 4.45B | 415.25M | |
P/E ratio | 2.47 | 1.52 | 5.05 | 9.33 | 0 | |
Price to sales ratio | 2.38 | 1.67 | 2.05 | 1.95 | 0 | |
POCF ratio | 8.95 | 6.2 | 7.73 | 15.18 | 0 | |
PFCF ratio | 14.78 | 8.3 | 17.72 | -90.34 | 0 | |
P/B Ratio | 1.24 | 0.91 | 0.95 | 0.7 | 0 | |
PTB ratio | 1.24 | 0.91 | 0.95 | 0.7 | 0 | |
EV to sales | 2.62 | 1.75 | 2.17 | 2.23 | 0.2 | |
Enterprise value over EBITDA | 8.21 | 5.26 | 14.88 | 13.35 | 0.77 | |
EV to operating cash flow | 9.86 | 6.52 | 8.2 | 17.31 | 0 | |
EV to free cash flow | 16.3 | 8.71 | 18.79 | -103.02 | 0 | |
Earnings yield | 0.1 | 0.16 | 0.05 | 0.03 | 0 | |
Free cash flow yield | 0.07 | 0.12 | 0.06 | -0.01 | 0 | |
Debt to equity | 0.19 | 0.1 | 0.13 | 0.13 | 0.12 | |
Debt to assets | 0.14 | 0.08 | 0.11 | 0.1 | 0.1 | |
Net debt to EBITDA | 0.76 | 0.25 | 0.85 | 1.64 | 0.77 | |
Current ratio | 1.6 | 2.1 | 1.51 | 1.33 | 1.29 | |
Interest coverage | 36.64 | 50.1 | 19.3 | 6 | 19.76 | |
Income quality | 1.11 | 0.98 | 2.61 | 2.46 | 0 | |
Dividend Yield | 0.03 | 0.05 | 0.06 | 0.04 | 0 | |
Payout ratio | 0.31 | 0.3 | 1.18 | 1.34 | 0 | |
Sales general and administrative to revenue | 0.06 | 0.05 | 0.05 | 0.06 | 0 | |
Research and developement to revenue | 0.05 | 0.04 | 0.03 | 0.04 | 0.02 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -0.39 | -0.25 | -0.56 | -1.17 | 0 | |
Capex to revenue | -0.1 | -0.07 | -0.15 | -0.15 | 0 | |
Capex to depreciation | -10.49 | -5.74 | -10.16 | -1.49 | 0 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 10.68 | 13.28 | 7.03 | 4.4 | 0 | |
ROIC | 0.11 | 0.13 | 0.04 | 0.02 | 0.04 | |
Return on tangible assets | 0.09 | 0.12 | 0.04 | 0.02 | 0.04 | |
Graham Net | -0.91 | -0.23 | -0.44 | -0.58 | 0 | |
Working capital | 807.25M | 1.12B | 574.83M | 349.75M | 341.16M | |
Tangible asset value | 5.47B | 5.88B | 5.54B | 5.5B | 5.8B | |
Net current asset value | 102.91M | 727.15M | 265.33M | 130.05M | 283.76M | |
Invested capital | 0.19 | 0.1 | 0.13 | 0.13 | 0.12 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 14.54 | 12.1 | 10.06 | 13.39 | 15.29 | |
Days payables outstanding | 10.6 | 26.72 | 8.55 | 8.93 | 9.97 | |
Days of inventory on hand | 64.18 | 54.33 | 41.24 | 49.33 | 49.47 | |
Receivables turnover | 6.19 | 7.44 | 8.94 | 6.72 | 5.89 | |
Payables turnover | 8.49 | 3.37 | 10.52 | 10.08 | 9.02 | |
Inventory turnover | 1.4 | 1.66 | 2.18 | 1.82 | 1.82 | |
ROE | 0.13 | 0.15 | 0.05 | 0.02 | 0.05 | |
Capex per share | -0.35 | -0.27 | -0.47 | -0.36 | 0 |
0746.HK Frequently Asked Questions
What is Lee & Man Chemical Company Limited stock symbol ?
Lee & Man Chemical Company Limited is a HK stock and trading under the symbol 0746.HK
What is Lee & Man Chemical Company Limited stock quote today ?
Lee & Man Chemical Company Limited stock price is $3.23 today.
Is Lee & Man Chemical Company Limited stock public?
Yes, Lee & Man Chemical Company Limited is a publicly traded company.